Qvanteq

Description

Qvanteq develops biofunctional surfaces that address clinical adverse effects in medical devices and vascular stents, using Qstent technology to reduce thrombus formation and speed healing in blood-contacting implants.

Qvanteq is located in the Zurich ecosystem.

Related

• SSkopeSkope develops vendor‑agnostic MRI hardware and monitoring solutions, including NeuroCam head coils and field‑monitoring systems, to…
• Synapse MedicineSynapse Medicine builds clinical decision-support software that analyses prescriptions and medication data to detect interactions, adverse…
• Nimble DiagnosticsNimble Diagnostics develops a non-invasive, portable monitoring device that detects stent complications, measuring stent malfunction with…
• Reha-StimReha-Stim provides gait-rehabilitation technology, including the GT II end-effector trainer, FLOAT robotic 3D body-weight support, and…
• BioretecBioretec develops and manufactures absorbable orthopedic implants (RemeOs™ metal alloy and Activa™ PLGA) for fracture treatment used by…
• MESIMESI builds integrated diagnostic hardware and software (MESI mTABLET and modular measurement devices) for clinicians to perform vital…
• SuSoSSuSoS provides functional surface-coating design, prototyping, agile coating services, IP licensing, and technology transfers for…
• NeuromodNeuromod develops and commercializes Lenire, a bimodal neuromodulation medical device for treating tinnitus, supplying clinicians and…
• AcytronixAcytronix provides PMED, a portable microstructured electrochemical device that rapidly isolates extracellular vesicles from biofluids…